|
CN104382899A
|
|
Compound medicine composition of mezlocillin sodium and sulbactam sodium
|
|
CN104151186A
|
|
Tigecycline impurity stereoselective preparation method
|
|
CN104030943A
|
|
A preparing process of lacosamide
|
|
CN103910721A
|
|
Aztreonam preparation method
|
|
CN103910704A
|
|
Preparation method of nebivolol and its intermediate compound
|
|
CN102924449A
|
|
H crystal form of moxifloxacin hydrochloride, preparation method thereof and medical composition
|
|
CN103113389A
|
|
Preparation method of sulbenicillin sodium
|
|
CN103058911A
|
|
Oxiracetam preparation technology
|
|
CN102260213B
|
|
Method for preparing tolvaptan
|
|
CN102633686A
|
|
Preparation method of peramivir
|
|
CN102058583A
|
|
Ticarcillin sodium clavulanic acid potassium freeze-dried powder as well as preparation and preparation method thereof
|
|
CN101974022A
|
|
Process for purifying cefsulodin sodium by solvent crystallization method
|
|
CN101973906A
|
|
Preparation method of amorphous tigecycline
|
|
CN102260298B
|
|
Method for synthesizing 1,2,3-O-triacetyl-5-deoxy-bata-D-ribose
|
|
CN102319221A
|
|
Cefsulodin sodium lyophilized powder, cefsulodin sodium lyophilized powder preparation and their preparation method
|
